CREATING MOLECULAR DIAGNOSTICS TO ENABLE THERAPEUTIC INTERVENTION

AltheaDx provides a start-to-finish suite of services focused on molecular biomarker discovery, assay development, assay validation and prospective/retrospective clinical trial testing in support of companion diagnostic development and commercialization. At the core of our services is a comprehensive set of gene expression and genotyping analysis capabilities for both pre-clinical and clinical applications utilizing state of the art genomics tools including real-time PCR, microarray technologies and next-generation sequencing. All of our services can be run under non-GLP, full GLP compliance and CLIA.